Financial Instruments Measured at Fair Value (Tables)

3 Months Ended

Mar. 28, 2015

Fair Value Disclosures [Abstract]

Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis Table [Text Block]

The following table presents assets (liabilities) measured at fair value on a recurring basis at March 28, 2015:

	Level 1		Level 2		Level 3			Total
Available-for-sale securities	$	38,946	$	—	$	—		$	38,946
Interest rate swaps	—		1,353		—			1,353
Foreign exchange contracts	—		588		—			588
Contingent consideration	—		—		(3,361		)	(3,361		)
	$	38,946	$	1,941	$	(3,361	)	$	37,526

The following table presents assets (liabilities) measured at fair value on a recurring basis at December 31, 2014:

	Level 1		Level 2		Level 3			Total
Cash equivalents	$	99,000	$	—	$	—		$	99,000
Available-for-sale securities	38,109		—		—			38,109
Interest rate swaps	—		378		—			378
Foreign exchange contracts	—		694		—			694
Contingent consideration	—		—		(6,202		)	(6,202		)
	$	137,109	$	1,072	$	(6,202	)	$	131,979

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

The following table summarizes the Level 3 activity for the first quarter of 2015:

Balance as of December 31, 2014	$	(6,202	)
Fair value of initial contingent consideration	—
Change in fair value of contingent consideration included in earnings	(325		)
Payment of contingent consideration (a)	3,000
Foreign currency translation adjustment	166
Balance as of March 28, 2015	$	(3,361	)

(a) Contingent consideration payment relates to an acquisition completed prior to 2015.

Available-for-sale Securities [Text Block]

The fair value of the company's available-for-sale securities at March 28, 2015 is as follows:

	Marubun		Mutual Funds
Cost basis	$	10,016	$	16,868
Unrealized holding gain	5,544		6,518
Fair value	$	15,560	$	23,386

The fair value of the company's available-for-sale securities at December 31, 2014 is as follows:

	Marubun		Mutual Funds
Cost basis	$	10,016	$	16,233
Unrealized holding gain	6,174		5,686
Fair value	$	16,190	$	21,919

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Text Block]

The fair values of derivative instruments in the company's consolidated balance sheets are as follows:

	Asset (Liability) Derivatives
		Fair Value
	Balance Sheet Location	March 28, 2015			December 31, 2014
Derivative instruments designated as hedges:
Interest rate swaps designated as fair value hedges	Other liabilities	$	—		$	(3	)
Interest rate swaps designated as fair value hedges	Other assets	1,353			381
Foreign exchange contracts designated as cash flow hedges	Other current assets	4,009			960
Foreign exchange contracts designated as cash flow hedges	Accrued expenses	(769		)	(376		)
Total derivative instruments designated as hedging instruments		4,593			962
Derivative instruments not designated as hedges:
Foreign exchange contracts	Other current assets	877			2,404
Foreign exchange contracts	Accrued expenses	(3,529		)	(2,294		)
Total derivative instruments not designated as hedging instruments		(2,652		)	110
Total		$	1,941		$	1,072

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Text Block]

The effect of derivative instruments on the company's consolidated statements of operations is as follows:

	Gain (Loss) Recognized in Income
	Quarter Ended
	March 28, 2015		March 29, 2014
Fair value hedges:
Interest rate swaps (a)	$	—	$	—
Total	$	—	$	—
Derivative instruments not designated as hedges:
Foreign exchange contracts (b)	$	808	$	1,913
Total	$	808	$	1,913

	Cash Flow Hedges
	Interest Rate Swaps (c)			Foreign Exchange Contracts (d)
Quarter Ended March 28, 2015
Effective portion:
Gain recognized in other comprehensive income	$	827		$	2,682
Loss reclassified into income	$	(161	)	$	(841	)
Ineffective portion:
Gain recognized in income	$	69		$	—
Quarter Ended March 29, 2014
Effective portion:
Loss recognized in other comprehensive income	$	—		$	(368	)
Gain (loss) reclassified into income	$	(161	)	$	136
Ineffective portion:
Gain (loss) recognized in income	$	—		$	—

(a) The amount of gain (loss) recognized in income on derivatives is recorded in "Interest and other financing expense, net" in the company's consolidated statements of operations.

(b) The amount of gain (loss) recognized in income on derivatives is recorded in "Cost of sales" in the company's consolidated statements of operations.

(c) Both the effective and ineffective portions of any gain (loss) reclassified or recognized in income are recorded in "Interest and other financing expense, net" in the company's consolidated statements of operations. The gain (loss) amounts reclassified into income relate to the termination of swaps.

(d) Both the effective and ineffective portions of any gain (loss) reclassified or recognized in income are recorded in "Cost of sales" in the company's consolidated statements of operations.